SMS Pharmaceuticals Limited · NSE: SMSPHARMA · BSE: 532815
SMS Pharmaceuticals
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 31 Jul 2026.
Q1 FY27 · Consolidated
Revenue
206.96₹ Cr
+5.6% vs year ago
Net profit
20.91₹ Cr
+2.0% vs year ago
EPS, basic
2.23₹
−3.5% vs year ago
Net margin
10.1%
−0.3 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 206.96 | +5.6% | 20.91 | +2.0% | 2.23 | 31 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 237.95 | −4.1% | 32.71 | +61.0% | 3.58 | 22 May 2026 |
| Q3 FY26Oct–Dec 2025 | 210.45 | +21.4% | 23.47 | +28.7% | 2.59 | 07 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 242.43 | +23.2% | 25.31 | +79.5% | 2.84 | 08 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 196.05 | +19.2% | 20.49 | +24.3% | 2.31 | 09 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 248.20 | +1.0% | 20.31 | +17.6% | 2.40 | 30 May 2025 |
| Q3 FY25Oct–Dec 2024 | 173.35 | +7.4% | 18.24 | +58.9% | 2.15 | 12 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 196.75 | +18.1% | 14.10 | +20.2% | 1.69 | 08 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 164.45 | +21.5% | 16.48 | +76.4% | 1.95 | 22 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 245.80 | +64.5% | 17.28 | +177.9% | 2.04 | 19 Jul 2024 |
| Q3 FY24Oct–Dec 2023 | 161.48 | +8.5% | 11.48 | +205.0% | 1.36 | 20 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 166.64 | +4.5% | 11.73 | Turned profit | 1.39 | 22 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 135.34 | +110.2% | 9.34 | Turned profit | 1.10 | 08 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 149.43 | +145.3% | 6.22 | +0.7% | 0.73 | 24 May 2023 |
| Q3 FY23Oct–Dec 2022 | 148.80 | +22.7% | 3.76 | −63.3% | 0.44 | 10 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 159.43 | −8.7% | (2.01) | Turned loss | (0.24) | 24 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 64.39 | −60.5% | (12.77) | Turned loss | (1.51) | 06 Sep 2022 |
| Q4 FY22Jan–Mar 2022 | 60.92 | — | 6.17 | — | 0.73 | 13 Jun 2022 |
| Q3 FY22Oct–Dec 2021 | 121.25 | −18.5% | 10.27 | −52.0% | 1.07 | 09 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 174.70 | +34.3% | 23.03 | +105.1% | 2.72 | 17 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 163.00 | +44.4% | 23.20 | +230.1% | 2.74 | 07 Aug 2021 |
| Q3 FY21Oct–Dec 2020 | 148.87 | +85.0% | 21.39 | +185.2% | 2.53 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 130.13 | +10.4% | 11.23 | +17.6% | 1.33 | 09 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 112.90 | −3.6% | 7.03 | −9.5% | 0.83 | 12 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 96.47 | −7.0% | 6.25 | −3.5% | 0.76 | 06 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 80.45 | — | 7.50 | — | 0.90 | 13 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 117.90 | — | 9.55 | — | 1.17 | 18 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 117.14 | — | 7.77 | — | 0.92 | 13 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 103.71 | — | 6.48 | — | 0.76 | 30 May 2019 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 206.96 | +5.6% | 21.13 | +16.1% | 2.26 | 31 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 237.95 | −4.1% | 20.92 | +1.4% | 2.29 | 22 May 2026 |
| Q3 FY26Oct–Dec 2025 | 210.45 | +21.4% | 23.34 | +35.9% | 2.57 | 07 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 242.43 | +23.2% | 25.14 | +76.3% | 2.82 | 08 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 196.05 | +19.2% | 18.21 | +11.5% | 2.05 | 09 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 248.20 | +1.0% | 20.62 | +29.5% | 2.43 | 30 May 2025 |
| Q3 FY25Oct–Dec 2024 | 173.35 | +7.4% | 17.17 | +41.1% | 2.03 | 12 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 196.75 | +18.1% | 14.26 | +18.4% | 1.68 | 08 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 164.45 | +21.5% | 16.33 | +75.9% | 1.93 | 22 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 245.80 | +64.5% | 15.92 | +97.2% | 1.88 | 19 Jul 2024 |
| Q3 FY24Oct–Dec 2023 | 161.48 | +8.5% | 12.17 | +142.1% | 1.44 | 20 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 166.64 | +4.5% | 12.05 | 15x | 1.42 | 22 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 135.34 | +110.2% | 9.28 | Turned profit | 1.10 | 08 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 149.43 | +145.3% | 8.07 | −10.9% | 0.95 | 24 May 2023 |
| Q3 FY23Oct–Dec 2022 | 148.80 | +22.7% | 5.03 | −52.1% | 0.59 | 10 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 159.43 | −8.7% | 0.79 | −96.9% | 0.09 | 24 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 64.39 | −60.5% | (9.81) | Turned loss | (1.16) | 06 Sep 2022 |
| Q4 FY22Jan–Mar 2022 | 60.92 | −64.4% | 9.06 | −60.8% | 1.07 | 13 Jun 2022 |
| Q3 FY22Oct–Dec 2021 | 121.25 | −18.5% | 10.51 | −42.7% | 1.24 | 09 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 174.70 | +34.3% | 25.27 | +125.1% | 2.99 | 17 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 163.00 | +44.4% | 23.20 | +152.1% | 2.74 | 07 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 171.29 | +77.6% | 23.14 | +270.3% | 2.73 | 31 May 2021 |
| Q3 FY21Oct–Dec 2020 | 148.87 | +85.0% | 18.32 | +144.3% | 2.16 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 130.13 | +10.4% | 11.23 | +17.6% | 1.33 | 09 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 112.90 | −3.6% | 9.20 | −2.9% | 1.09 | 12 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 96.47 | −7.0% | 6.25 | −3.5% | 0.74 | 06 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 80.45 | −20.5% | 7.50 | −38.5% | 0.89 | 13 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 117.90 | −12.6% | 9.55 | −24.0% | 1.13 | 18 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 117.14 | −6.4% | 9.48 | −6.3% | 1.12 | 13 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 103.71 | — | 6.48 | — | 0.76 | 30 May 2019 |
| Q3 FY19Oct–Dec 2018 | 101.25 | — | 12.19 | — | 1.44 | 16 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 134.84 | — | 12.56 | — | 1.48 | 12 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 125.11 | — | 10.11 | — | 1.19 | 30 Jul 2018 |
62 filings on record for this company.